Zhou C - Search Results

1

A novel nonpeptide ligand for formyl peptide receptor-like 1.

Nanamori M, Cheng X, Mei J, Sang H, Xuan Y, Zhou C, Wang MW, Ye RD. Nanamori M, et al. Among authors: zhou c. Mol Pharmacol. 2004 Nov;66(5):1213-22. doi: 10.1124/mol.104.004309. Epub 2004 Aug 12. Mol Pharmacol. 2004. PMID: 15308762

2

Pharmacological characterization of a novel nonpeptide antagonist for formyl peptide receptor-like 1.

Zhou C, Zhang S, Nanamori M, Zhang Y, Liu Q, Li N, Sun M, Tian J, Ye PP, Cheng N, Ye RD, Wang MW. Zhou C, et al. Mol Pharmacol. 2007 Oct;72(4):976-83. doi: 10.1124/mol.107.037564. Epub 2007 Jul 25. Mol Pharmacol. 2007. PMID: 17652444

3

Stereospecific induction of nuclear factor-kappaB activation by isochamaejasmin.

Tian Q, Li J, Xie X, Sun M, Sang H, Zhou C, An T, Hu L, Ye RD, Wang MW. Tian Q, et al. Among authors: zhou c. Mol Pharmacol. 2005 Dec;68(6):1534-42. doi: 10.1124/mol.105.014720. Epub 2005 Sep 1. Mol Pharmacol. 2005. PMID: 16141313

4

The immunosuppressant cyclosporin A antagonizes human formyl peptide receptor through inhibition of cognate ligand binding.

Yan P, Nanamori M, Sun M, Zhou C, Cheng N, Li N, Zheng W, Xiao L, Xie X, Ye RD, Wang MW. Yan P, et al. Among authors: zhou c. J Immunol. 2006 Nov 15;177(10):7050-8. doi: 10.4049/jimmunol.177.10.7050. J Immunol. 2006. PMID: 17082621

5

Discovery of Trp-Nle-Tyr-Met as a novel agonist for human formyl peptide receptor-like 1.

Wan HX, Zhou C, Zhang Y, Sun M, Wang X, Yu H, Yang X, Ye RD, Shen JK, Wang MW. Wan HX, et al. Among authors: zhou c. Biochem Pharmacol. 2007 Jul 15;74(2):317-26. doi: 10.1016/j.bcp.2007.04.016. Epub 2007 Apr 22. Biochem Pharmacol. 2007. PMID: 17517377

6

V101L of human formyl peptide receptor 1 (FPR1) increases receptor affinity and augments the antagonism mediated by cyclosporins.

Zhou C, Zhou Y, Wang J, Feng Y, Wang H, Xue J, Chen Y, Ye RD, Wang MW. Zhou C, et al. Among authors: zhou y. Biochem J. 2013 Apr 15;451(2):245-55. doi: 10.1042/BJ20121839. Biochem J. 2013. PMID: 23373827 Free PMC article.

7

Rhodanine derivatives as novel peroxisome proliferator-activated receptor gamma agonists.

Liu Q, Zhang YY, Lu HL, Li QY, Zhou CH, Wang MW. Liu Q, et al. Acta Pharmacol Sin. 2007 Dec;28(12):2033-9. Acta Pharmacol Sin. 2007. PMID: 18031620

8

Non-peptidic glucose-like peptide-1 receptor agonists: aftermath of a serendipitous discovery.

Wang MW, Liu Q, Zhou CH. Wang MW, et al. Acta Pharmacol Sin. 2010 Sep;31(9):1026-30. doi: 10.1038/aps.2010.107. Epub 2010 Aug 2. Acta Pharmacol Sin. 2010. PMID: 20676118 Free PMC article.

9

Development of β-amino-carbonyl compounds as androgen receptor antagonists.

Zhang ZY, Zhu YH, Zhou CH, Liu Q, Lu HL, Ge YJ, Wang MW. Zhang ZY, et al. Acta Pharmacol Sin. 2014 May;35(5):664-73. doi: 10.1038/aps.2013.201. Acta Pharmacol Sin. 2014. PMID: 24786235 Free PMC article.

10

Development of a homogeneous calcium mobilization assay for high throughput screening of mas-related gene receptor agonists.

Zhang R, Yan PK, Zhou CH, Liao JY, Wang MW. Zhang R, et al. Acta Pharmacol Sin. 2007 Jan;28(1):125-31. doi: 10.1111/j.1745-7254.2007.00451.x. Acta Pharmacol Sin. 2007. PMID: 17184592

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,844 results

Search Page

Filters